Health Catalyst Capital

About The Fund

Health Catalyst Capital (HCC) is a New York-based private equity firm that specializes in investing in high-growth healthcare information technology and tech-enabled services businesses. Dedicated to the future of healthcare, HCC targets innovative U.S.-based Health IT companies that align with specific key themes, each holding the potential to reach $1 billion in enterprise value in new or disrupted global markets. Their investment focus is on the lower middle market where they can leverage their operational experience and industry expertise to the greatest effect, ensuring significant growth prospects and capital appreciation potential for their investments. HCC operates on the principle that technological solutions are imperative in the U.S. healthcare system to enhance the quality of care, access, and affordability, particularly within a non-cyclical market with annual spending exceeding $4 trillion. Their portfolio strategy encompasses investing in enterprises with strong growth dynamics that meet their specific investment criteria, including a minimum investment of $9,250,000 and a maximum of $11,000,000. This approach is designed to stimulate meaningful advancements within the healthcare sector. HCC's investors comprise a diversified group that includes large healthcare organizations, institutional investors, family offices, as well as healthcare entrepreneurs and senior executives who share HCC's vision and commitment to transforming healthcare through strategic investments.